FDA To Require Adverse Event E-Submissions For “AERS II” Launch
FDA will start requiring the electronic submission of adverse event reports for implementation of its second-generation Adverse Event Reporting System database in 2007-2008
You may also be interested in...
FDA is making increased use of data mining software to identify early drug safety signals in its adverse event database, Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman said
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011